D K Hossfeld
Overview
Explore the profile of D K Hossfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
279
Citations
1813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Goekkurt E, Hoehn S, Wolschke C, Wittmer C, Stueber C, Hossfeld D, et al.
Br J Cancer
. 2005 Dec;
94(2):281-6.
PMID: 16317430
To evaluate the predictive value of a panel of gene polymorphisms involved in metabolism of 5-FU and cisplatin on clinical outcome in advanced gastric cancer patients. A total of 52...
12.
Schuch G, Oliveira-Ferrer L, Loges S, Laack E, Bokemeyer C, Hossfeld D, et al.
Leukemia
. 2005 Jun;
19(8):1312-7.
PMID: 15931265
Increased vessel density in the bone marrow of patients with acute myeloid leukemia as well as elevated expression of proangiogenic factors by leukemic cells implies a central role of angiogenesis...
13.
Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Reiter A, et al.
Leukemia
. 2005 Apr;
19(6):984-9.
PMID: 15830009
Gender-related aspects in chronic myeloid leukemia (CML) have not been studied well. We therefore analyzed 856 patients with Ph/BCR-ABL-positive CML from the German randomized CML-studies I (interferon alpha (IFN) vs...
14.
Josting A, Rudolph C, Mapara M, Glossmann J, Sieniawski M, Sienawski M, et al.
Ann Oncol
. 2004 Dec;
16(1):116-23.
PMID: 15598948
Background: We designed a dose- and time-intensified high-dose sequential chemotherapy regimen for patients with relapsed and refractory Hodgkin lymphoma (HD). Patients And Methods: Eligibility criteria included age 18-65 years, histologically...
15.
de Wit M, Raabe A, Seegers B, Buchert R, Beck-Bornholdt H, Alberti W, et al.
Int J Radiat Biol
. 2004 Sep;
80(7):529-39.
PMID: 15360091
Purpose: To determine the sensitivity and specificity of 18F-fluorodeoxyglucose-positron-emission tomography (FDG-PET) in the diagnosis of R1H tumours after fractionated radiotherapy, and the dependency of sensitivity and specificity on time after...
16.
Laack E, Dickgreber N, Muller T, Knuth A, Benk J, Lorenz C, et al.
J Clin Oncol
. 2004 Jun;
22(12):2348-56.
PMID: 15197195
Purpose: To evaluate whether cisplatin-based chemotherapy (gemcitabine, vinorelbine, and cisplatin [GVP]) prolongs overall survival in comparison to cisplatin-free chemotherapy (gemcitabine and vinorelbine [GV]) as first-line treatment in patients with advanced...
17.
18.
Muller M, Gattermann N, Lahaye T, Deininger M, Berndt A, Fruehauf S, et al.
Leukemia
. 2003 Oct;
17(12):2392-400.
PMID: 14523462
We sought to determine dynamics of BCR-ABL mRNA expression levels in 139 patients with chronic myelogenous leukemia (CML) in early chronic phase, randomized to receive imatinib (n=69) or interferon (IFN)/Ara-C...
19.
Berger U, Engelich G, Maywald O, Pfirrmann M, Hochhaus A, Reiter A, et al.
Leukemia
. 2003 Sep;
17(9):1820-6.
PMID: 12970782
Chronic myeloid leukemia (CML) in older patients has not been studied well. To assess the long-term outcome of older patients with Philadelphia- and/or BCR-ABL-positive CML, 199 patients aged >/=60 years...
20.
Einsele H, Bamberg M, Budach W, Schmidberger H, Hess C, Wormann B, et al.
Bone Marrow Transplant
. 2003 Sep;
32(6):593-9.
PMID: 12953132
The overall survival of patients with advanced multiple myeloma (MM) undergoing high-dose chemotherapy and autologous stem cell transplantation (SCT) depends mainly on the quality of response. Thus, to improve the...